HB1321

Relative to the regulation of the provision of elective intravenous therapy.

Introduced·12/1/25
Text Text

New Hampshire HB1321 regulates the provision of elective intravenous therapy, defining it and restricting its administration to licensed medical.

New Hampshire HB1321 amends RSA 329 to regulate the provision of elective intravenous therapy. It defines "elective intravenous therapy" as a procedure to administer fluids, nutrients, medications, or blood directly into a patient's bloodstream to alleviate temporary discomfort or improve wellness. The bill specifies that such therapy can only be administered by licensed medical professionals in a physician's office or a licensed health facility. It also mandates that only certain licensed professionals can prescribe or order this therapy. The act will take effect 60 days after its passage.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

DD
2
0
Democratic CaucusRepublican Caucus

Calendar

Feb 18

2:30 PM

Health, Human Services and Elderly Affairs Executive Session

Feb 11

10:30 AM

Health, Human Services and Elderly Affairs Public Hearing

History

Mar 5

House

Inexpedient to Legislate: Motion Adopted Voice Vote 03/05/2026 House Journal 6 P. 19

Feb 25

House

Committee Report: Inexpedient to Legislate 02/18/2026 (Vote 18-0; Consent Calendar) House Calendar 9 P. 16

Feb 11

House

Executive Session: 02/18/2026 02:30 pm GP 158